Literature DB >> 34718064

Effects and signaling pathways of Elabela in the cardiovascular system.

Meiling Zhou1, Yinan Wu2.   

Abstract

For a long time, Apelin has been considered as the only endogenous ligand of G protein-coupled receptor APJ. Until recently, the discovery of Elabela (Apela/Toddler) as a new polypeptide that can act through APJ and has a similar function to Apelin broke this situation. Elabela promotes a variety of cell proliferation processes, including embryonic development, and has especially beneficial effects in the cardiovascular system. In this review, we summarize the biological functions of Elabela and review its specific roles in cardiovascular diseases and the signaling pathways mediated by it.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular system; Circulating hormone; Elabela; Signaling pathways; Treatment

Mesh:

Substances:

Year:  2021        PMID: 34718064     DOI: 10.1016/j.peptides.2021.170674

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.

Authors:  Kamran Rakhshan; Masoomeh Sharifi; Fatemeh Ramezani; Yaser Azizi; Nahid Aboutaleb
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

2.  The role of potassium channels on vasorelaxant effects of elabela in rat thoracic aorta.

Authors:  Serdar Şahintürk; Naciye İşbil
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.